10-KPeriod: FY2010

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2010

Filed February 10, 2011For Securities:UNH

Summary

UnitedHealth Group (UNH) reported strong financial performance for the fiscal year ending December 31, 2010. The company experienced significant revenue growth, driven by its Health Benefits segment, particularly in the public and senior markets, and by premium rate increases reflecting underlying medical cost trends. Despite an increase in operating costs, UNH demonstrated improved profitability, with earnings from operations and net earnings both showing substantial year-over-year growth. The company also highlighted its strategic business realignment efforts in early 2011, aimed at better responding to market dynamics. Investors should note UNH's substantial participation in government health care programs, such as Medicare Advantage and Medicaid, which are subject to regulatory changes and reimbursement adjustments. The company's robust cash flow from operations and strong balance sheet position provide financial flexibility. Management is actively managing medical costs and operational efficiencies to navigate the evolving healthcare landscape, including the implications of the recently enacted Health Reform Legislation.

Financial Statements
Beta
Revenue$94.16B
Cost of Revenue$2.12B
Gross Profit$92.04B
SG&A Expenses$14.27B
Operating Expenses$86.29B
Operating Income$7.86B
Interest Expense$481.00M
Net Income$4.63B
EPS (Basic)$4.14
EPS (Diluted)$4.10
Shares Outstanding (Basic)1.12B
Shares Outstanding (Diluted)1.13B

Key Highlights

  • 1Total revenues increased to $94.16 billion, an 8% increase from the prior year, driven by strong performance in the Health Benefits segment.
  • 2Earnings from operations grew by 24% to $7.86 billion, while net earnings increased by 21% to $4.63 billion.
  • 3The Health Benefits segment showed significant growth, with revenues up 8% and earnings from operations up 39%, reflecting strong performance in public and senior markets.
  • 4UnitedHealth Group's medical care ratio improved to 80.6% from 82.3% in the prior year, largely due to favorable development of prior period medical costs and effective cost management.
  • 5The company returned capital to shareholders through $2.5 billion in share repurchases and increased its quarterly dividend payment.
  • 6Ingenix segment revenue grew significantly (28%), although its operating margin decreased due to a goodwill impairment and charges related to a business line disposition.
  • 7UNH actively manages its capital structure, maintaining a debt-to-total-capital ratio of 30.1% as of December 31, 2010, and has a $2.5 billion revolving credit facility.

Frequently Asked Questions

In 2010, UnitedHealth Group reported total revenues of $94.16 billion, an increase of 8% from $87.14 billion in 2009. Net earnings grew by 21% to $4.63 billion, or $4.10 per diluted share, compared to $3.82 billion, or $3.24 per diluted share, in 2009. This growth was primarily driven by the Health Benefits segment.

The company acknowledged the significant impact of the Health Reform Legislation signed into law in 2010, which expanded coverage and modified various aspects of the healthcare system. UNH anticipated that the legislation would impact business operations, potentially restricting growth in certain segments, increasing costs, and altering revenue streams. They also noted that the legislation could present new opportunities for growth, particularly in their health services businesses.

UnitedHealth Group's strategy for managing medical costs involves underwriting criteria, product design, provider contract negotiations, and care management programs. For 2010, the medical care ratio was 80.6%, an improvement from 82.3% in 2009. This improvement was attributed to a moderation in medical service utilization, effective clinical engagement, and favorable development of prior period medical costs.

In 2010, UnitedHealth Group repurchased approximately $2.5 billion of its common stock. Additionally, the company increased its quarterly cash dividend to shareholders in May 2010, moving to a quarterly payment cycle of $0.125 per share.